Coffee and caffeine have long been popular beverages consumed by millions of people worldwide. But beyond just being a morning pick-me-up, new research suggests that moderate consumption of these caffeinated delights may actually have a protective effect against developing multiple cardiometabolic diseases.
A recent study published in the Journal of Clinical Endocrinology & Metabolism titled “Habitual Coffee, Tea and Caffeine Consumption, Circulating Metabolites, and the Risk of Cardiometabolic Multimorbidity” found that regular coffee or caffeine intake, especially at moderate levels, was associated with a lower risk of new-onset cardiometabolic multimorbidity (CM). This term refers to the coexistence of at least two cardiometabolic diseases, such as type 2 diabetes, coronary heart disease, and stroke.
The study, led by Chaofu Ke, M.D., Ph.D., from the Department of Epidemiology and Biostatistics at Suzhou Medical College of Soochow University in China, analyzed data from the UK Biobank, a large longitudinal dietary study with over 500,000 participants aged 37–73 years. The researchers found that individuals who consumed moderate amounts of coffee (three cups per day) or caffeine (200–300 mg per day) had the lowest risk for new-onset CM, with a 48.1% and 40.7% reduced risk, respectively.
The study also highlighted the potential benefits of promoting moderate coffee or caffeine intake as a dietary habit for healthy individuals. It found that moderate consumption of these beverages was inversely associated with almost all stages of CM development. This suggests that incorporating three cups of coffee or 200–300 mg of caffeine per day into one’s routine could help reduce the risk of developing multiple cardiometabolic diseases.
The researchers addressed a significant research gap by focusing on the effects of coffee, tea, and caffeine consumption on the development of CM. While previous studies had shown protective effects of these beverages on single cardiometabolic diseases, their impact on the development of multiple diseases was largely unknown. The findings from this study shed light on the potential benefits of coffee and caffeine in preventing CM and reducing the associated risks of mortality, loss of physical function, and mental stress.
In conclusion, the study adds to the growing body of evidence supporting the health benefits of moderate coffee and caffeine consumption. By incorporating these beverages into their daily routine, individuals may be able to lower their risk of developing multiple cardiometabolic diseases and improve their overall health and well-being. This research underscores the importance of balanced and moderate consumption of coffee and caffeine as part of a healthy lifestyle.
